
  
    
      
        Background_NNP
        Androgens_NNP are_VBP central_JJ to_TO sexual_JJ differentiation_NN and_CC the_DT
        maintenance_NN of_IN male_JJ secondary_JJ sexual_JJ characteristics_NNS and_CC
        functions_NNS ._. Individuals_NNS with_IN inactivating_VBG mutations_NNS of_IN their_PRP$
        androgen_NN receptor_NN (_( AR_NNP )_) (_( androgen_NN insensitivity_NN syndromes_NNS
        (_( AIS_NNP )_) )_) are_VBP phenotypically_RB female_JJ in_IN appearance_NN and_CC behavior_NN
        and_CC lack_NN male_JJ sex_NN accessory_JJ organs_NNS (_( prostate_NN ,_, seminal_NN
        vesicles_NNS and_CC Cowper_NNP 's_POS glands_NNS )_) despite_IN the_DT presence_NN of_IN
        testes_NNS ,_, high_JJ levels_NNS of_IN testosterone_NN and_CC a_DT Y_NNP chromosome_NN [_NN
        1_CD ]_NN ._. The_DT effects_NNS of_IN androgens_NNS are_VBP cell-specific_JJ and_CC
        developmental_NN stage-specific_JJ ._. For_IN instance_NN ,_, castration_NN of_IN
        an_DT adult_NN male_JJ does_VBZ not_RB change_VB the_DT external_JJ genitalia_NN or_CC
        voice_NN pitch_NN ,_, but_CC causes_VBZ a_DT profound_JJ involution_NN of_IN the_DT
        prostate_NN ,_, particularly_RB in_IN the_DT epithelial_NN compartment_NN [_NN 2_CD ,_,
        3_CD ]_NN ._. The_DT exquisite_JJ sensitivity_NN of_IN prostatic_JJ epithelial_NN cells_NNS
        to_TO androgens_NNS has_VBZ been_VBN exploited_VBN therapeutically_RB in_IN the_DT
        management_NN of_IN prostate_NN cancer_NN [_NN 4_CD ]_NN ._.
        The_DT mechanisms_NNS underlying_VBG the_DT temporal_JJ and_CC
        tissue-specific_JJ effects_NNS of_IN androgens_NNS are_VBP not_RB understood_VBN ._.
        Like_IN all_DT steroid_NN hormones_NNS ,_, androgens_NNS act_VBP by_IN binding_VBG to_TO a_DT
        nuclear_JJ hormone_NN receptor_NN ,_, enacting_VBG conformational_NN changes_NNS
        that_WDT allow_VBP binding_VBG of_IN the_DT receptor_NN to_TO specific_JJ regulatory_JJ
        elements_NNS in_IN AR-responsive_NNP genes_NNS ._. The_DT ensuing_VBG cascade_NN of_IN
        transcriptional_NN events_NNS ,_, unique_JJ to_TO each_DT cell_NN type_NN ,_, underlies_NNS
        the_DT dramatic_JJ and_CC diverse_JJ effects_NNS of_IN androgen_NN ._. Understanding_NNP
        the_DT molecular_JJ programs_NNS regulated_VBN by_IN androgens_NNS in_IN critical_JJ
        target_NN tissues_NNS may_MD lead_VB to_TO improvements_NNS in_IN treatment_NN of_IN AIS_NNP
        in_IN children_NNS ,_, benign_JJ prostatic_JJ hyperplasia_NN and_CC prostate_NN
        cancer_NN in_IN adult_NN men_NNS ,_, and_CC diverse_JJ other_JJ conditions_NNS in_IN which_WDT
        androgens_NNS play_VBP a_DT key_JJ role_NN ._.
        Unfortunately_RB ,_, few_JJ model_NN systems_NNS are_VBP available_JJ for_IN
        studying_VBG the_DT effects_NNS of_IN androgens_NNS in_IN human_JJ tissues_NNS ._. There_EX
        are_VBP no_DT practical_JJ models_NNS of_IN early_JJ development_NN ,_, when_WRB androgen_NN
        exerts_NNS its_PRP$ most_RBS striking_JJ effects_NNS on_IN the_DT genitalia_NN ,_, body_NN
        habitus_JJ and_CC brain_NN ._. Only_RB a_DT handful_NN of_IN immortalized_JJ cell_NN
        lines_NNS express_VBP AR_NNP and_CC respond_VB to_TO its_PRP$ ligands_NNS ._. All_DT of_IN these_DT
        cell_NN lines_NNS have_VBP been_VBN isolated_VBN from_IN patients_NNS with_IN advanced_JJ
        prostate_NN carcinomas_NNS that_WDT have_VBP become_VBN refractory_JJ to_TO androgen_NN
        deprivation_NN therapy_NN [_NN 5_CD ,_, 6_CD ,_, 7_CD ]_NN ._. In_IN three_CD of_IN these_DT cell_NN
        lines_NNS ,_, LNCaP_NNP ,_, MDA_NNP PCa_NNP 2_CD a_DT and_NN MDA_NNP PCa_NNP 2_CD b_SYM ,_, mutations_NNS in_IN the_DT
        ligand-binding_JJ domain_NN of_IN the_DT AR_NNP confer_VB broad_JJ
        steroid-binding_JJ affinity_NN [_NN 8_CD ,_, 9_CD ]_NN ._. A_DT fourth_JJ cell_NN line_NN ,_,
        LAPC-_NNP 4_CD ,_, bears_VBZ a_DT wild-type_JJ AR_NNP ._.
        As_IN an_DT initial_JJ foray_NN into_IN understanding_NN androgen-mediated_JJ
        gene_NN regulation_NN ,_, we_PRP used_VBD cDNA_NN microarrays_NNS to_TO characterize_VB
        the_DT transcriptional_NN program_NN activated_VBN by_IN the_DT synthetic_JJ
        androgen_NN R_NN 1881_CD in_IN these_DT four_CD human_JJ prostate_NN cancer_NN cell_NN
        lines_NNS ._. The_DT results_NNS provide_VBP a_DT broad_JJ overview_NN of_IN
        characterized_VBN and_CC uncharacterized_JJ genes_NNS modulated_JJ by_IN
        androgens_NNS and_CC identify_VB many_JJ previously_RB unknown_JJ androgen_NN
        targets_NNS ._. The_DT similarity_NN of_IN the_DT transcriptional_NN responses_NNS
        among_IN the_DT four_CD androgen-responsive_JJ cell_NN lines_NNS suggests_VBZ that_IN
        this_DT expression_NN program_NN may_MD be_VB intrinsic_JJ to_TO prostatic_JJ
        epithelial_NN cell_NN function_NN ._. Indeed_RB ,_, most_JJS of_IN the_DT functionally_RB
        characterized_VBN genes_NNS induced_VBN by_IN androgen_NN in_IN these_DT prostatic_JJ
        cells_NNS appear_VBP to_TO have_VB important_JJ roles_NNS in_IN the_DT production_NN of_IN
        seminal_NN fluid_JJ ._.
      
      
        Results_NNS and_CC discussion_NN
        In_IN our_PRP$ initial_JJ experiments_NNS ,_, we_PRP focused_VBD exclusively_RB on_IN
        the_DT well-characterized_JJ LNCaP_NNP human_JJ prostate_NN cancer_NN cell_NN
        line_NN ._. LNCaP_NNP cells_NNS were_VBD cultured_JJ in_IN conditions_NNS of_IN androgen_NN
        deprivation_NN for_IN 48_CD hours_NNS ,_, then_RB exposed_VBN to_TO 1_CD nM_NN of_IN the_DT
        synthetic_JJ androgen_NN R_NN 1881_CD or_CC to_TO ethanol_NN control_NN (_( 0_CD ._. 01_CD %_NN )_) ._.
        After_IN treatment_NN for_IN intervals_NNS varying_VBG from_IN 8_CD to_TO 72_CD hours_NNS ,_,
        poly_RB (_( A_DT )_) +_NN RNA_NNP was_VBD extracted_VBN from_IN the_DT cells_NNS and_CC analyzed_VBD
        using_VBG DNA_NNP microarrays_NNS ._. Two_CD types_NNS of_IN array_NN analyses_NNS were_VBD
        performed_VBN ._. In_IN the_DT first_JJ ,_, mRNA_NN from_IN each_DT sample_NN of_IN treated_VBN
        or_CC control_NN cells_NNS was_VBD reverse_VB transcribed_JJ to_TO produce_VB
        Cys-labeled_NNP cDNA_NN ,_, and_CC this_DT was_VBD compared_VBN to_TO a_DT '_POS common_JJ
        reference_NN '_'' of_IN Cy_NNP 3_CD -_: labeled_VBN cDNA_NN prepared_VBN from_IN mRNA_NN extracted_VBN
        from_IN several_JJ cell_NN lines_NNS [_NN 10_CD ]_NN ._. These_DT experiments_NNS revealed_VBD
        changes_NNS in_IN expression_NN of_IN several_JJ hundred_CD genes_NNS in_IN the_DT
        R_NN 1881_CD -_: treated_VBN LNCaP_NNP cells_NNS ,_, but_CC no_DT corresponding_JJ alterations_NNS
        in_IN the_DT ethanol-treated_JJ control_NN (_( data_NNS not_RB shown_VBN )_) ._. As_IN the_DT
        ethanol_NN control_NN treatment_NN did_VBD not_RB appear_VB to_TO affect_VB gene_NN
        expression_NN significantly_RB ,_, we_PRP analyzed_VBD another_DT similar_JJ R_NN 1881_CD
        time_NN course_NN in_IN which_WDT cDNAs_NNS representing_VBG transcripts_NNS from_IN
        treated_VBN (_( Cy-_NNP 5_CD labeled_VBN )_) and_CC control_NN (_( Cy-_NNP 3_CD labeled_VBN )_) cells_NNS
        were_VBD compared_VBN directly_RB by_IN hybridization_NN to_TO the_DT same_JJ
        microarrays_NNS ._. Measured_VBN changes_NNS in_IN gene-expression_JJ patterns_NNS
        were_VBD virtually_RB identical_JJ to_TO those_DT observed_VBD in_IN the_DT first_JJ
        experiment_NN ._. The_DT remaining_VBG experiments_NNS were_VBD carried_VBN out_IN
        using_VBG the_DT direct_JJ comparative_JJ hybridization_NN design_NN ._.
        The_DT significance_NN analysis_NN of_IN microarrays_NNS (_( SAM_NNP )_) procedure_NN
        was_VBD used_VBN to_TO identify_VB genes_NNS with_IN statistically_RB significant_JJ
        changes_NNS in_IN expression_NN after_IN treatment_NN with_IN R_NN 1881_CD ._. The_DT SAM_NNP
        procedure_NN accurately_RB identifies_VBZ transcripts_NNS with_IN
        reproducible_JJ changes_NNS in_IN gene_NN expression_NN and_CC is_VBZ more_RBR
        reliable_JJ than_IN conventional_JJ means_NNS of_IN analyzing_VBG microarrays_NNS [_NN
        11_CD ]_NN ._. Hierarchical_NNP clustering_VBG of_IN the_DT expression_NN patterns_NNS of_IN
        567_CD transcripts_NNS representing_VBG 517_CD unique_JJ genes_NNS with_IN
        statistically_RB significant_JJ changes_NNS in_IN expression_NN in_IN response_NN
        to_TO 1_CD nM_NN R_NN 1881_CD in_IN LNCaP_NNP is_VBZ displayed_VBN in_IN Figure_NN 1_CD a_DT ._.
        Expression_NNP levels_NNS changed_VBD more_JJR than_IN twofold_NN in_IN 539_CD (_( 95_CD %_NN )_) of_IN
        the_DT transcripts_NNS ._. The_DT raw_JJ microarray_NN data_NNS and_CC full_JJ details_NNS
        including_VBG transcript_NN identities_NNS can_MD be_VB found_VBN at_IN [_NN 12_CD ]_NN ._.
        Approximately_RB one_CD third_NN of_IN these_DT transcripts_NNS represent_VBP
        uncharacterized_JJ and_CC unnamed_JJ genes_NNS and_CC were_VBD not_RB previously_RB
        known_VBN to_TO be_VB regulated_VBN by_IN androgen_NN ._. Of_IN the_DT named_VBN genes_NNS ,_, many_JJ
        have_VBP not_RB been_VBN previously_RB recognized_VBN as_IN responsive_JJ to_TO
        androgen_NN ._. Virtually_RB all_DT of_IN the_DT known_VBN androgen-regulated_JJ
        genes_NNS that_WDT were_VBD represented_VBN on_IN the_DT array_NN and_CC adequately_RB
        measured_VBN responded_VBD as_RB previously_RB reported_VBD (_( Figure_NN 1_CD b_SYM )_) ._.
        To_TO further_VB examine_VB the_DT expression_NN changes_NNS induced_VBN in_IN
        response_NN to_TO androgen_NN ,_, we_PRP conducted_VBD two_CD additional_JJ sets_NNS of_IN
        experiments_NNS ._. In_IN the_DT first_JJ ,_, LNCaP_NNP cells_NNS were_VBD treated_VBN for_IN 24_CD
        hours_NNS with_IN dihydrotestosterone_NN (_( DHT_NNP )_) ,_, the_DT predominant_NN
        androgen_NN found_VBD in_IN the_DT prostate_NN 
        in_IN vivo_NN ._. A_DT clear_JJ relationship_NN was_VBD
        observed_VBN between_IN increasing_VBG dose_NN of_IN DHT_NNP and_CC increased_VBN
        levels_NNS of_IN gene_NN expression_NN (_( Figure_NN 2_CD aand_NN see_VB Additional_JJ data_NNS
        files_NNS )_) ._. Furthermore_RB ,_, the_DT pattern_NN of_IN expression_NN changes_NNS
        observed_VBD in_IN response_NN to_TO DHT_NNP largely_RB paralleled_JJ those_DT
        observed_VBD after_IN treatment_NN with_IN R_NN 1881_CD (_( R_NN 2_CD =_SYM 0_CD ._. 7705_CD ;_: Figure_NN
        2_CD b_SYM )_) ._. We_PRP conducted_VBD a_DT second_RB set_NN of_IN experiments_NNS to_TO examine_VB
        the_DT response_NN of_IN LNCaP_NNP cells_NNS to_TO androgen_NN withdrawal_NN ._. After_IN
        carrying_VBG cells_NNS in_IN androgen-replete_JJ media_NNS with_IN
        charcoal-stripped_JJ fetal_JJ bovine_JJ serum_NN (_( FBS_NNP )_) (_( supplemented_JJ
        with_IN 1_CD nM_NN R_NN 1881_CD )_) ,_, cells_NNS were_VBD passaged_JJ in_IN media_NNS without_IN
        androgen_NN and_CC harvested_VBN at_IN 48_CD and_CC 70_CD hours_NNS (_( Figure_NN 2_CD a_DT )_) ._.
        After_IN 48_CD hours_NNS ,_, the_DT change_NN in_IN gene-expression_JJ pattern_NN was_VBD
        largely_RB reciprocal_JJ to_TO that_DT induced_VBN by_IN androgen_NN treatment_NN
        and_CC these_DT effects_NNS increased_VBN by_IN 70_CD hours_NNS ._. For_IN the_DT
        SAM-selected_NNP gene_NN set_VBD ,_, expression_NN patterns_NNS after_IN 70_CD hours_NNS
        of_IN androgen_NN deprivation_NN were_VBD inversely_RB correlated_JJ with_IN
        those_DT seen_VBN 50_CD hours_NNS after_IN R_NN 1881_CD treatment_NN (_( R_NN 2_CD =_SYM 0_CD ._. 7119_CD ;_:
        Figure_NN 2_CD c_SYM )_) ._.
        We_PRP have_VBP previously_RB observed_VBN that_WDT varied_VBD stimuli_NNS produce_VBP
        temporally_RB complex_JJ changes_NNS in_IN gene-expression_JJ patterns_NNS in_IN
        yeast_NN and_CC mammalian_JJ cells_NNS 
        in_IN vitro_NN [_NN 13_CD ,_, 14_CD ,_, 15_CD ]_NN ._. In_IN many_JJ
        cases_NNS ,_, genes_NNS can_MD be_VB grouped_VBN by_IN their_PRP$ expression_NN patterns_NNS
        using_VBG hierarchical_JJ clustering_VBG ,_, and_CC these_DT groups_NNS often_RB
        comprise_VBP genes_NNS that_WDT are_VBP functionally_RB related_VBN ._. To_TO our_PRP$
        surprise_NN ,_, genes_NNS in_IN the_DT SAM-generated_NNP dataset_NN varied_VBD little_JJ
        in_IN their_PRP$ expression_NN between_IN 8_CD and_CC 72_CD hours_NNS after_IN androgen_NN
        treatment_NN ._. In_IN general_JJ ,_, expression_NN levels_NNS of_IN genes_NNS induced_VBN
        or_CC repressed_VBN by_IN androgen_NN treatment_NN remained_VBD at_IN a_DT constant_JJ
        level_NN between_IN 8_CD and_CC 72_CD hours_NNS ._. As_IN the_DT SAM_NNP procedure_NN
        identified_VBD genes_NNS with_IN significant_JJ changes_NNS in_IN expression_NN in_IN
        androgen-treated_JJ cells_NNS compared_VBN to_TO controls_NNS ,_, we_PRP were_VBD
        concerned_VBN that_IN genes_NNS had_VBD been_VBN excluded_VBN whose_WP$ expression_NN
        levels_NNS varied_VBD for_IN only_RB part_NN of_IN the_DT time_NN course_NN ._. Analysis_NNP of_IN
        the_DT raw_JJ data_NN by_IN hierarchical_JJ clustering_VBG analysis_NN alone_RB
        again_RB generally_RB failed_VBD to_TO identify_VB genes_NNS whose_WP$ expression_NN
        varied_VBD over_IN the_DT time_NN course_NN ._. The_DT lack_NN of_IN complexity_NN in_IN the_DT
        temporal_JJ response_NN to_TO androgen_NN in_IN this_DT dataset_NN precludes_VBZ
        useful_JJ grouping_VBG of_IN genes_NNS based_VBN on_IN differences_NNS in_IN their_PRP$
        responses_NNS by_IN cluster_NN analysis_NN ._. Perhaps_RB a_DT more_RBR detailed_JJ
        investigation_NN of_IN expression_NN changes_NNS within_IN the_DT first_JJ 8_CD
        hours_NNS after_IN treatment_NN will_MD reveal_VB temporal_JJ patterns_NNS of_IN
        response_NN of_IN LNCaP_NNP to_TO androgens_NNS and_CC provide_VB additional_JJ
        insights_NNS into_IN androgen_NN action_NN ._.
        We_PRP were_VBD curious_JJ to_TO know_VB whether_IN the_DT expression_NN changes_NNS
        observed_VBD in_IN LNCaP_NNP would_MD also_RB occur_VB in_IN other_JJ
        androgen-responsive_JJ human_JJ prostate_NN cancer_NN cell_NN lines_NNS (_( MDA_NNP
        PCa_NNP 2_CD a_DT ,_, MDA_NNP PCa_NNP 2_CD b_SYM ,_, and_CC LAPC-_NNP 4_LS )_) ,_, or_CC in_IN LNCaP_NNP and_CC LAPC-_NNP 4_CD
        subclones_NNS carried_VBD in_IN androgen-depleted_JJ conditions_NNS for_IN
        extended_VBN periods_NNS ._. All_DT cell_NN lines_NNS were_VBD treated_VBN with_IN 1_CD nM_NN
        R_NN 1881_CD and_CC at_IN least_JJS one_CD sample_NN was_VBD collected_VBN between_IN 20_CD and_CC
        70_CD hours_NNS after_IN addition_NN of_IN R_NN 1881_CD ._. RNA_NNP samples_NNS from_IN treated_VBN
        and_CC control_NN cell_NN lines_NNS were_VBD compared_VBN directly_RB on_IN the_DT same_JJ
        microarray_NN ._. Responses_NNS to_TO androgen_NN of_IN the_DT set_NN of_IN transcripts_NNS
        identified_VBN as_IN androgen-responsive_JJ in_IN the_DT LNCaP_NNP experiments_NNS
        were_VBD examined_VBN in_IN each_DT of_IN these_DT cell_NN lines_NNS ._. Many_JJ genes_NNS were_VBD
        modulated_JJ similarly_RB in_IN all_DT of_IN the_DT cell_NN lines_NNS ,_, suggesting_VBG
        conservation_NN of_IN a_DT specific_JJ androgen-responsive_JJ program_NN ,_,
        perhaps_RB a_DT vestige_NN of_IN the_DT prostatic_JJ epithelial_NN phenotype_NN ,_,
        between_IN these_DT cell_NN lines_NNS (_( Figure_NN 3_CD ;_: see_VB also_RB [_NN 12_CD ]_NN and_CC
        Additional_JJ data_NNS files_NNS )_) ._. For_IN example_NN ,_, the_DT transcript_NN levels_NNS
        of_IN 310_CD of_IN these_DT genes_NNS changed_VBN by_IN 1_CD ._. 5_CD -_: fold_VB or_CC more_JJR in_IN MDA_NNP
        PCa_NNP 2_CD a_DT and_NN 2_CD b_SYM cells_NNS following_VBG 48_CD hours_NNS of_IN exposure_NN to_TO
        R_NN 1881_CD ;_: transcripts_NNS for_IN 262_CD genes_NNS changed_VBN by_IN 1_CD ._. 5_CD -_: fold_VB or_CC
        greater_JJR in_IN single_JJ treatments_NNS of_IN all_DT four_CD LNCaP_NNP
        androgen-deprived_JJ subclones_NNS ;_: and_CC transcripts_NNS for_IN 81_CD genes_NNS
        changed_VBN by_IN 1_CD ._. 5_CD -_: fold_VB or_CC greater_JJR in_IN the_DT three_CD LAPC-_NNP 4_CD and_CC
        LAPC-_NNP 4_CD (_( androgen-deprived_JJ )_) array_NN experiments_NNS ._.
        There_EX were_VBD a_DT few_JJ noteworthy_JJ differences_NNS in_IN expression_NN
        profiles_NNS between_IN the_DT cell_NN lines_NNS ._. When_WRB we_PRP focused_VBD our_PRP$
        attention_NN on_IN transcripts_NNS whose_WP$ relative_JJ abundance_NN changed_VBN
        by_IN more_JJR than_IN 2_CD ._. 6_CD -_: fold_VB in_IN at_IN least_JJS two_CD experiments_NNS (_( [_NN 12_CD ]_NN
        and_CC see_VB Additional_JJ data_NNS files_NNS )_) ,_, one_CD group_NN of_IN genes_NNS differed_VBD
        strikingly_RB between_IN the_DT cell_NN lines_NNS (_( Figure_NN 4_LS )_) ._. Most_JJS of_IN the_DT
        genes_NNS in_IN this_DT group_NN have_VBP previously_RB been_VBN found_VBN to_TO be_VB
        consistently_RB expressed_VBN at_IN significantly_RB higher_JJR levels_NNS in_IN
        proliferating_VBG cells_NNS [_NN 10_CD ,_, 16_CD ]_NN ._. Treatment_NNP with_IN 1_CD nM_NN R_NN 1881_CD
        promotes_VBZ proliferation_NN in_IN the_DT MDA_NNP PCa_NNP 2_CD a_DT and_NN 2_CD b_SYM cell_NN lines_NNS ,_,
        has_VBZ no_DT proliferative_JJ effect_NN in_IN the_DT LNCaP_NNP and_CC LAPC-_NNP 4_CD cell_NN
        lines_NNS ,_, and_CC represses_NNS proliferation_NN in_IN LNCaP_NNP cell_NN lines_NNS
        carried_VBD for_IN prolonged_JJ periods_NNS in_IN conditions_NNS of_IN androgen_NN
        deprivation_NN (_( data_NNS not_RB shown_VBN ,_, and_CC see_VB references_NNS in_IN [_NN 17_CD ,_,
        18_CD ,_, 19_CD ]_NN )_) ._. As_IN seen_VBN in_IN Figure_NN 3_CD ,_, the_DT proliferation_NN cluster_NN is_VBZ
        relatively_RB induced_VBN in_IN the_DT MDA_NNP PCa_NNP 2_CD a_DT and_NN 2_CD b_SYM cell_NN lines_NNS ,_,
        shows_VBZ little_JJ change_NN in_IN LNCaP_NNP and_CC LAPC-_NNP 4_CD ,_, and_CC is_VBZ repressed_VBN
        in_IN the_DT androgen_NN deprived_VBD LNCaP_NNP cell_NN lines_NNS ._. Thus_RB ,_, transcript_NN
        levels_NNS of_IN the_DT genes_NNS in_IN this_DT proliferation_NN cluster_NN parallel_VB
        the_DT responses_NNS of_IN these_DT cell_NN lines_NNS to_TO treatment_NN with_IN
        androgens_NNS ._.
        The_DT expression_NN patterns_NNS induced_VBN by_IN R_NN 1881_CD offer_NN possible_JJ
        insights_NNS into_IN the_DT effects_NNS of_IN androgens_NNS in_IN prostate_NN
        physiology_NN ._. Many_JJ features_NNS of_IN the_DT androgen-induced_JJ
        expression_NN program_NN appear_VBP to_TO be_VB related_VBN to_TO activation_NN of_IN
        the_DT cell_NN 's_POS capacity_NN to_TO produce_VB seminal_NN fluid_JJ ._. After_IN
        puberty_NN ,_, the_DT normal_JJ prostate_NN produces_VBZ a_DT protein-_NN and_CC
        organic_JJ solute-rich_JJ fluid_NN that_WDT contributes_VBZ approximately_RB
        30_CD -_: 50_CD %_NN of_IN the_DT volume_NN of_IN the_DT ejaculate_NN ._. The_DT prostatic_JJ
        secretions_NNS are_VBP poorly_RB characterized_VBN ,_, but_CC are_VBP undoubtedly_RB
        critical_JJ to_TO fertility_NN as_IN the_DT prostate_NN is_VBZ the_DT only_JJ sex_NN
        accessory_JJ gland_NN present_JJ in_IN nearly_RB all_DT mammals_NNS [_NN 20_CD ]_NN ._.
        Androgen_NNP induces_VBZ several_JJ classes_NNS of_IN genes_NNS that_WDT contribute_VBP
        to_TO the_DT production_NN and_CC secretion_NN of_IN prostatic_JJ fluid_NN ._.
        Perhaps_RB the_DT most_RBS striking_JJ change_NN caused_VBN by_IN treatment_NN
        with_IN R_NN 1881_CD occurs_VBZ in_IN the_DT class_NN of_IN genes_NNS that_WDT contribute_VBP to_TO
        the_DT synthesis_NN and_CC modification_NN of_IN secretory_NN proteins_NNS ._. All_DT
        androgen-responsive_JJ genes_NNS in_IN this_DT class_NN show_NN increased_VBN
        expression_NN in_IN response_NN to_TO androgen_NN ._. We_PRP have_VBP previously_RB
        identified_VBN putative_JJ secretory_NN and_CC membrane-bound_JJ proteins_NNS
        based_VBN on_IN their_PRP$ synthesis_NN on_IN membrane-associated_JJ polysomes_NNS
        (_( [_NN 21_CD ]_NN and_CC M_NNP ._. D_NNP ._. and_CC P_NN ._. O_NNP ._. B_NNP ._. ,_, unpublished_JJ observations_NNS )_) and_CC
        over_IN 200_CD of_IN these_DT are_VBP among_IN the_DT androgen-responsive_JJ genes_NNS
        (_( see_VB [_NN 12_CD ]_NN and_CC Additional_JJ data_NNS files_NNS )_) ._. Included_VBN in_IN this_DT set_JJ
        are_VBP genes_NNS encoding_VBG proteins_NNS previously_RB known_VBN to_TO be_VB secreted_JJ
        by_IN the_DT prostate_NN into_IN the_DT seminal_NN plasma_NN ,_, including_VBG
        prostate-specific_JJ antigen_NN (_( PSA_NNP )_) ,_, sorbitol_NN dehydrogenase_NN ,_,
        apolipoprotein_NN D_NNP [_NN 22_CD ]_NN ,_, and_CC vascular_NN endothelial_NN growth_NN
        factor_NN (_( VEGF_NNP )_) [_NN 23_CD ]_NN ._. An_DT additional_JJ set_VBN consists_VBZ of_IN 30_CD
        androgen-responsive_JJ genes_NNS with_IN roles_NNS in_IN protein_NN trafficking_NN
        and_CC secretory_NN vesicle_NN formation_NN and_CC in_IN transport_NN of_IN
        secretory_NN vesicles_NNS (_( Figure_NN 5_CD a_DT )_) ._. This_DT set_NN of_IN genes_NNS includes_VBZ
        several_JJ with_IN roles_NNS in_IN membrane_NN budding_VBG ,_, vesicular_NN
        formation_NN ,_, and_CC membrane_NN fusion_NN ,_, and_CC translocation_NN of_IN
        proteins_NNS across_IN the_DT membrane_NN of_IN the_DT endoplasmic_JJ reticulum_NN ._.
        Androgen_NNP treatment_NN also_RB induced_VBD a_DT number_NN of_IN genes_NNS that_WDT
        participate_VBP in_IN protein_NN folding_NN and_CC glycosylation_NN (_( Figure_NN
        5_CD b_SYM )_) ._. One_CD of_IN these_DT ,_, FK_NNP 506_CD -_: binding_JJ protein_NN 5_CD /_NN FKBP_NNP 51_CD ,_, a_DT
        recently_RB described_VBN androgen_NN target_NN [_NN 24_CD ]_NN ,_, was_VBD the_DT most_RBS
        highly_RB induced_VBN gene_NN (_( more_JJR than_IN 20_CD -_: fold_VB )_) we_PRP observed_VBD in_IN our_PRP$
        experiments_NNS ._. FK_NNP 506_CD -_: binding_JJ protein_NN 5_CD /_NN FKBP_NNP 51_CD is_VBZ a_DT
        co-chaperone_JJ protein_NN that_WDT has_VBZ peptidylprolyl_NN isomerase_NN
        activity_NN and_CC interacts_NNS with_IN the_DT progesterone_NN receptor_NN [_NN
        25_CD ]_NN ._. Whether_IN it_PRP functions_NNS in_IN the_DT processing_NN of_IN
        androgen-induced_JJ secretory_NN proteins_NNS or_CC in_IN other_JJ pathways_NNS
        induced_VBN by_IN androgens_NNS or_CC perhaps_RB even_RB in_IN cell-cell_JJ signaling_VBG
        is_VBZ unclear_JJ ,_, but_CC the_DT degree_NN of_IN induction_NN suggests_VBZ it_PRP may_MD
        have_VB an_DT important_JJ role_NN in_IN prostatic_JJ physiology_NN ._.
        Prostatic_NNP fluid_NN is_VBZ also_RB rich_JJ in_IN small_JJ organic_JJ compounds_NNS
        that_WDT account_NN for_IN much_JJ of_IN its_PRP$ osmotic_JJ pressure_NN ._. For_IN
        instance_NN ,_, prostatic_JJ secretions_NNS contain_VBP the_DT highest_JJS levels_NNS
        of_IN polyamines_NNS of_IN all_DT bodily_RB fluids_NNS ._. The_DT transcript_NN encoding_VBG
        ornithine_NN decar-boxylase_JJ (_( ODC_NNP )_) ,_, a_DT known_VBN androgen_NN target_NN
        that_IN catalyzes_NNS the_DT rate-limiting_JJ step_NN in_IN polyamine_NN
        biosynthesis_NNS [_NN 26_CD ]_NN ,_, was_VBD induced_VBN coordinately_RB with_IN enzymes_NNS
        that_WDT catalyze_NN downstream_JJ steps_NNS in_IN polyamine_NN synthetic_JJ
        pathway_NN (_( spermine_NN synthase_NN ,_, spermidine_NN /_NN spermine_NN 
        N_NNP 1_CD -_: acetyltransferase_NN ,_, and_CC
        S-_NNP adenosylmethionine_NN decarboxylase_NN )_) (_( Figure_NN 5_CD c_SYM )_) ._.
        Cholesterol_NNP and_CC lipids_NNS are_VBP also_RB found_VBN at_IN high_JJ levels_NNS in_IN
        semen_NN and_CC are_VBP major_JJ components_NNS of_IN secretory_NN vesicles_NNS
        referred_VBD to_TO as_IN prostasomes_NNS ,_, which_WDT are_VBP thought_VBN to_TO regulate_VB
        the_DT function_NN of_IN spermatozoa_NN [_NN 27_CD ]_NN ._. Note_VB that_IN several_JJ genes_NNS
        for_IN proteins_NNS involved_VBN in_IN cholesterol_NN biosynthesis_NNS (_( HMG_NNP CoA_NNP
        reductase_NN ,_, IDI_NNP 1_CD ,_, sterol_NN C_NNP 4_CD methyl_NN oxidase_NN )_) and_CC fatty_NN acid_NN
        metabolism_NN (_( ACAT_NNP 2_CD ,_, DEGS_NNP ,_, ACATN_NNP ,_, FACL_NNP 3_CD ,_, PEC_NNP 1_LS )_) were_VBD modulated_JJ
        by_IN R_NN 1881_CD ._. Choline_NNP ,_, sorbitol_NN ,_, amino_JJ acids_NNS and_CC citrate_NN are_VBP
        also_RB found_VBN in_IN the_DT prostatic_JJ secretions_NNS ,_, although_IN only_RB a_DT few_JJ
        genes_NNS (_( for_IN sorbitol_NN dehy-drogenase_JJ ,_, phosphatidylcholine_NN
        transfer_NN protein_NN ,_, amino-acid_JJ transporter_NN )_) related_VBN to_TO these_DT
        pathways_NNS appeared_VBD to_TO respond_VB directly_RB to_TO androgen_NN ._. Citrate_NNP
        production_NN is_VBZ regulated_VBN by_IN transport_NN of_IN aspartate_NN into_IN the_DT
        mitochondria_NN by_IN aspartate_NN amino-transferase_JJ ,_, and_CC indeed_RB ,_,
        the_DT gene_NN encoding_VBG this_DT enzyme_NN was_VBD induced_VBN by_IN androgen_NN in_IN
        each_DT of_IN these_DT cell_NN lines_NNS [_NN 28_CD ]_NN ._. Genes_NNP encoding_VBG several_JJ
        mitochondrial_NN proteins_NNS were_VBD also_RB induced_VBN in_IN response_NN to_TO
        androgen_NN ,_, perhaps_RB reflecting_VBG the_DT increased_VBN production_NN of_IN
        citrate_NN ,_, or_CC the_DT increased_VBN demand_NN for_IN energy_NN in_IN these_DT cells_NNS
        as_IN they_PRP mobilize_VB secretory_NN pathways_NNS ._.
        Zinc_NNP ,_, calcium_NN ,_, phosphate_NN ,_, potassium_NN ,_, sodium_NN ,_, chloride_NN
        and_CC other_JJ ions_NNS are_VBP abundant_JJ in_IN the_DT ejaculate_NN ,_, although_IN
        sodium_NN and_CC chloride_NN are_VBP at_IN levels_NNS below_IN their_PRP$ serum_NN
        concentrations_NNS ._. Several_JJ transporter_NN molecules_NNS and_CC
        ion-channel_JJ genes_NNS which_WDT may_MD have_VB roles_NNS in_IN the_DT active_JJ
        transfer_NN of_IN these_DT ions_NNS into_IN and_CC out_IN of_IN the_DT lumen_NN of_IN the_DT
        prostate_NN acini_NN and_CC secretory_NN granules_NNS were_VBD modulated_JJ in_IN
        response_NN to_TO R_NN 1881_CD (_( Figure_NN 5_CD d_SYM )_) ._. Transport_NNP of_IN sodium_NN and_CC
        chloride_NN out_IN of_IN the_DT lumen_NN of_IN the_DT prostate_NN acini_NN is_VBZ
        accompanied_VBN by_IN the_DT passive_JJ transfer_NN of_IN water_NN and_CC the_DT
        prostatic_JJ secretions_NNS are_VBP thereby_RB concentrated_VBN [_NN 20_CD ]_NN ._.
        Transport_NNP of_IN ions_NNS and_CC small_JJ organic_JJ compounds_NNS into_IN the_DT
        acinar_NN lumen_NN will_MD concentrate_VB them_PRP in_IN the_DT seminal_NN plasma_NN ._.
        The_DT 
        ank_NN gene_NN ,_, which_WDT codes_NNS for_IN a_DT
        transmembrane_NN protein_NN that_IN secretes_NNS pyrophosphate_NN into_IN
        joint_JJ spaces_NNS [_NN 29_CD ]_NN ,_, was_VBD strongly_RB induced_VBN by_IN R_NN 1881_CD exposure_NN ._.
        Our_PRP$ data_NNS suggests_VBZ that_IN the_DT pyrophosphate_NN in_IN the_DT ejaculate_NN
        maybe_RB secreted_JJ into_IN the_DT prostatic_JJ fluid_NN by_IN the_DT ANK_NNP
        protein_NN ._.
        The_DT prostate_NN undergoes_NNS dramatic_JJ morphologic_JJ changes_NNS as_IN
        it_PRP acquires_VBZ the_DT ability_NN to_TO produce_VB seminal_NN fluid_JJ ,_, and_CC these_DT
        changes_NNS can_MD be_VB observed_VBN at_IN puberty_NN or_CC by_IN stimulating_VBG the_DT
        prostate_NN with_IN androgens_NNS after_IN castration_NN ._. The_DT epithelial_NN
        cells_NNS proliferate_VBP and_CC change_NN from_IN stratified_JJ to_TO cuboidal_NN ,_,
        while_IN glands_NNS branch_NN and_CC acini_NN expand_VB ._. These_DT morphologic_JJ
        changes_NNS follow_VBP complex_JJ reprogramming_VBG of_IN the_DT prostate_NN cell_NN
        that_WDT involves_VBZ poorly_RB understood_VBN alterations_NNS of_IN the_DT
        cytoskeleton_NN and_CC the_DT extracellular_NN matrix_NN and_CC changes_NNS in_IN
        downstream_JJ signaling_VBG pathways_NNS [_NN 30_CD ,_, 31_CD ]_NN ._. Many_JJ genes_NNS
        encoding_VBG components_NNS of_IN the_DT extracellular_NN matrix_NN ,_, proteins_NNS
        important_JJ in_IN cell-cell_JJ interactions_NNS and_CC cytoskeletal_NN
        proteins_NNS were_VBD regulated_VBN in_IN response_NN to_TO R_NN 1881_CD ,_, suggesting_VBG
        that_IN they_PRP may_MD participate_VB in_IN the_DT morphologic_JJ changes_NNS
        induced_VBN by_IN androgens_NNS (_( Figure_NN 6_CD a_DT ,_, 6_CD b_SYM )_) ._. Many_JJ previous_JJ studies_NNS
        have_VBP pointed_VBN to_TO a_DT critical_JJ role_NN for_IN the_DT cytoskeleton_NN and_CC
        extracellular_NN matrix_NN in_IN transducing_VBG signals_NNS for_IN growth_NN ,_,
        differentiation_NN and_CC secretion_NN in_IN normal_JJ and_CC cancerous_JJ
        prostate_NN cells_NNS [_NN 32_CD ]_NN ._. Our_PRP$ data_NNS may_MD therefore_RB help_VB point_VB to_TO
        one_CD important_JJ feature_NN of_IN the_DT transcriptional_NN program_NN that_IN
        sets_VBZ the_DT stage_NN for_IN these_DT signaling_VBG events_NNS ._.
        We_PRP also_RB found_VBD evidence_NN of_IN modulation_NN of_IN several_JJ genes_NNS
        encoding_VBG transcriptional_NN regulatory_JJ and_CC signaling_VBG proteins_NNS
        in_IN response_NN to_TO androgen_NN in_IN the_DT prostate_NN cancer_NN cell_NN lines_NNS
        (_( Figure_NN 6_CD c_SYM ,_, 6_CD d_SYM )_) ._. It_PRP is_VBZ possible_JJ that_IN some_DT of_IN these_DT pathways_NNS
        have_VBP important_JJ roles_NNS in_IN reprogramming_VBG the_DT normal_JJ prostate_NN
        cell_NN in_IN response_NN to_TO androgen_NN [_NN 33_CD ]_NN ._. However_RB ,_, some_DT of_IN these_DT
        signaling_VBG and_CC transcriptional_NN proteins_NNS may_MD be_VB modulated_JJ
        abnormally_RB in_IN these_DT cancer-derived_JJ cell_NN lines_NNS because_IN of_IN
        molecular_JJ genetic_JJ alterations_NNS acquired_VBN with_IN transformation_NN
        [_NN 34_CD ,_, 35_CD ]_NN ._. Yet_RB other_JJ pathways_NNS may_MD not_RB be_VB direct_JJ targets_NNS of_IN
        AR_NNP activation_NN but_CC could_MD be_VB modulated_JJ in_IN response_NN to_TO
        androgen-induced_JJ changes_NNS in_IN the_DT internal_JJ or_CC external_JJ milieu_NN
        of_IN the_DT cells_NNS ._. For_IN instance_NN ,_, treatment_NN of_IN LNCaP_NNP with_IN
        androgens_NNS has_VBZ been_VBN shown_VBN to_TO cause_VB a_DT burst_NN of_IN oxidative_JJ
        stress_NN that_WDT may_MD contribute_VB to_TO prostate_NN carcinogenesis_NNS [_NN
        19_CD ]_NN ._. The_DT observed_VBD increased_VBN expression_NN of_IN NFκB_NNP and_CC several_JJ
        DNA_NNP repair_NN and_CC stress-response_JJ genes_NNS may_MD be_VB a_DT secondary_JJ
        response_NN to_TO this_DT oxidative_JJ stress_NN rather_RB than_IN a_DT direct_JJ
        response_NN to_TO AR_NNP signaling_VBG [_NN 36_CD ]_NN ._. Further_RB work_NN will_MD clearly_RB
        be_VB necessary_JJ to_TO dissect_NN the_DT roles_NNS of_IN these_DT signaling_VBG
        pathways_NNS in_IN the_DT response_NN of_IN the_DT prostate_NN to_TO AR_NNP
        activation_NN ._.
        In_IN summary_NN ,_, we_PRP have_VBP provided_VBN a_DT global_JJ characterization_NN
        of_IN the_DT gene-expression_JJ programs_NNS triggered_VBN by_IN androgen_NN
        exposure_NN in_IN human_JJ prostate_NN cancer_NN cells_NNS ._. Analysis_NNP of_IN the_DT
        gene-expression_JJ program_NN induced_VBN by_IN R_NN 1881_CD strongly_RB suggests_VBZ
        that_IN all_DT of_IN these_DT prostate_NN cancer_NN cell_NN lines_NNS retain_VBP
        features_NNS of_IN prostatic_JJ epithelial_NN cells_NNS ,_, despite_IN being_VBG
        derived_VBN from_IN prostate_NN cancer_NN metastases_NNS and_CC despite_IN their_PRP$
        long_JJ propagation_NN 
        in_IN vitro_NN ._. We_PRP recognize_VBP that_IN the_DT 
        in_IN vitro_NN model_NN systems_NNS used_VBN here_RB
        offer_NN at_IN best_JJS only_RB an_DT approximation_NN of_IN normal_JJ and_CC cancerous_JJ
        prostatic_JJ epithelia_NN ._. Nevertheless_RB ,_, we_PRP believe_VBP that_IN many_JJ of_IN
        the_DT target_NN genes_NNS identified_VBN in_IN these_DT experiments_NNS are_VBP likely_JJ
        to_TO be_VB regulated_VBN similarly_RB 
        in_IN vivo_NN ,_, just_RB as_IN PSA_NNP clearly_RB is_VBZ ,_, and_CC
        might_MD serve_VB as_RB clinically_RB useful_JJ diagnostic_JJ markers_NNS or_CC
        therapeutic_JJ targets_NNS ._. These_DT data_NNS may_MD also_RB offer_VB some_DT insight_NN
        into_IN the_DT contribution_NN of_IN the_DT prostate_NN to_TO the_DT normal_JJ seminal_NN
        fluid_JJ ,_, including_VBG molecular_JJ components_NNS that_WDT may_MD be_VB important_JJ
        in_IN fertility_NN ._. Further_RB investigation_NN into_IN androgen-induced_JJ
        changes_NNS in_IN gene_NN and_CC protein_NN expression_NN 
        in_IN vitro_NN and_CC 
        in_IN vivo_NN will_MD undoubtedly_RB shed_VB light_JJ
        on_IN prostatic_JJ physiology_NN and_CC prostatic_JJ carcinoma_NN ,_, and_CC also_RB
        on_IN broader_JJR physiological_JJ functions_NNS of_IN androgen_NN ._. Beyond_IN
        applications_NNS of_IN these_DT data_NNS to_TO studies_NNS on_IN the_DT role_NN of_IN
        androgen_NN in_IN prostatic_JJ cells_NNS ,_, this_DT work_NN provides_VBZ a_DT
        foundation_NN for_IN future_JJ investigation_NN into_IN androgen_NN signaling_VBG
        in_IN other_JJ model_NN systems_NNS ._. Comparison_NNP of_IN the_DT transcriptional_NN
        programs_NNS induced_VBN by_IN androgen_NN in_IN other_JJ examples_NNS of_IN the_DT
        diverse_JJ cells_NNS and_CC tissues_NNS that_WDT respond_VBP to_TO androgen_NN will_MD
        undoubtedly_RB contribute_VB to_TO a_DT molecular_JJ understanding_NN of_IN the_DT
        basis_NN of_IN the_DT diverse_JJ and_CC profound_JJ effects_NNS of_IN androgens_NNS on_IN
        human_JJ development_NN and_CC physiology_NN and_CC in_IN human_JJ diseases_NNS ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Cell_NNP culture_NN and_CC androgen_NN treatments_NNS
          The_DT LNCaP_NNP cell_NN line_NN was_VBD obtained_VBN from_IN the_DT ATCC_NNP and_CC
          maintained_VBN in_IN RPMI_NNP media_NNS with_IN 10_CD %_NN FBS_NNP and_CC
          penicillin_NN /_NN streptomycin_NN ._. The_DT LN_NNP 95_CD ,_, LN_NNP 96_CD ,_, LN_NNP 97_CD ,_, and_CC LN_NNP 98_CD
          variants_NNS of_IN LNCaP_NNP ,_, designated_VBN by_IN the_DT year_NN in_IN which_WDT
          androgen-free_JJ culture_NN was_VBD initiated_VBN [_NN 18_CD ]_NN ,_, were_VBD
          maintained_VBN in_IN RPMI_NNP media_NNS without_IN phenol_NN red_JJ and_CC with_IN 10_CD %_NN
          charcoal-stripped_JJ ,_, dextran-filtered_JJ FBS_NNP (_( Hyclone_NNP ,_, Logan_NNP ,_,
          UT_NNP )_) and_CC penicillin_NN /_NN streptomycin_NN ._. The_DT MDA_NNP PCa_NNP 2_CD a_DT and_NN MDA_NNP
          PCa_NNP 2_CD b_SYM cells_NNS were_VBD generously_RB provided_VBN by_IN Nora_NNP Navone_NNP at_IN
          the_DT University_NNP of_IN Texas_NNP M_NNP ._. D_NNP ._. Anderson_NNP Cancer_NNP Center_NNP and_CC
          were_VBD cultured_JJ in_IN defined_VBN BRFF-HPC_NNP 1_CD media_NNS (_( Biological_NNP
          Research_NNP Faculty_NN &_CC Facility_NNP ,_, Ijamsville_NNP ,_, MD_NNP )_) and_CC
          maintained_VBN on_IN poly-lysine-coated_JJ tissue_NN culture_NN plates_NNS
          (_( Becton_NNP Dickinson_NNP Labware_NNP ,_, Franklin_NNP Lakes_NNP ,_, NJ_NNP )_) ._. The_DT
          LAPC-_NNP 4_CD cells_NNS were_VBD cultured_JJ in_IN Iscove_NNP 's_POS media_NNS with_IN 10_CD %_NN FBS_NNP
          and_CC penicillin_NN /_NN streptomycin_NN ,_, and_CC the_DT androgen-deprived_JJ
          variant_NN LAPC-_NNP 4_CD AD_NNP was_VBD maintained_VBN in_IN Iscove_NNP 's_POS without_IN
          phenol_NN red_JJ and_CC with_IN 10_CD %_NN charcoal-stripped_JJ FBS_NNP ._.
          Before_IN androgen_NN treatments_NNS ,_, LNCaP_NNP and_CC LAPC-_NNP 4_CD cells_NNS
          were_VBD androgen-deprived_JJ by_IN 48_CD h_NN culture_NN in_IN media_NNS without_IN
          phenol_NN red_JJ ,_, containing_VBG 10_CD %_NN dextran-filtered_JJ ,_,
          charcoal-stripped_JJ FBS_NNP ._. For_IN the_DT MDA_NNP cells_NNS ,_, media_NNS was_VBD F_NN 12_CD K_NNP
          supplemented_JJ with_IN 1_CD %_NN charcoal-stripped_JJ FBS_NNP ,_, 40_CD mM_NN
          phosphoethanolamine_NN ,_, 10_CD pg_NN /_NN ml_NN hydrocortisone_NN ,_, 45_CD nM_NN
          selenious_JJ acid_NN ,_, 5_CD μg_NN /_NN ml_NN insulin_NN ,_, and_CC 10_CD ng_NN /_NN ml_NN epidermal_NN
          growth_NN factor_NN (_( EGF_NNP )_) [_NN 6_CD ]_NN ._. After_IN androgen_NN deprivation_NN ,_,
          cells_NNS were_VBD treated_VBN with_IN either_DT R_NN 1881_CD or_CC DHT_NNP (_( NEN_NNP Life_NNP
          Science_NNP Products_NNPS ,_, Boston_NNP ,_, MA_NNP )_) dissolved_VBN in_IN ethanol_NN ,_, or_CC
          ethanol_NN carrier_NN alone_RB ,_, and_CC incubated_JJ for_IN varying_VBG lengths_NNS
          of_IN time_NN ._. The_DT final_JJ concentration_NN of_IN ethanol_NN in_IN media_NNS was_VBD
          0_CD ._. 01_CD %_NN ._. Messenger_NNP RNA_NNP was_VBD prepared_VBN from_IN cells_NNS using_VBG the_DT
          Oligotex_NNP Direct_NNP kit_NN for_IN direct_JJ isolation_NN of_IN
          polyadenylated_JJ RNAs_NNP (_( Qiagen_NNP ,_, Chatsworth_NNP ,_, CA_NNP )_) ._.
        
        
          DNA_NN microarray_NN hybridizations_NNS and_CC data_NNS
          analysis_NN
          The_DT DNA_NNP microarrays_NNS used_VBN in_IN this_DT study_NN consisted_VBD of_IN
          PCR-amplified_NNP cDNAs_NNS printed_VBN on_IN modified_VBN glass_NN microscope_NN
          slides_NNS as_IN described_VBN previously_RB [_NN 37_CD ]_NN ._. Each_DT array_NN
          contained_VBD 24_CD ,_, 000_CD cDNA_NN spots_NNS ,_, representing_VBG approximately_RB
          18_CD ,_, 000_CD unique_JJ human_JJ genes_NNS and_CC expressed_VBD sequence_NN tags_NNS
          (_( ESTs_NNP )_) ._. Some_DT of_IN the_DT samples_NNS were_VBD also_RB analyzed_VBN on_IN
          microarrays_NNS with_IN 9_CD ,_, 600_CD cDNA_NN elements_NNS ._. Microarray_NNP
          hybridizations_NNS were_VBD carried_VBN out_IN according_VBG to_TO previously_RB
          published_VBN protocols_NNS [_NN 14_CD ,_, 37_CD ,_, 38_CD ,_, 39_CD ]_NN ._. For_IN each_DT
          hybridization_NN ,_, 2_CD μg_NN of_IN each_DT purified_JJ sample_NN of_IN
          polyadenylated_JJ RNA_NNP was_VBD reverse-transcribed_JJ in_IN the_DT
          presence_NN of_IN fluorescently_RB labeled_VBN nucleoside_NN
          triphosphates_NNS (_( Cy_NNP 3_CD -_: dUTP_NN for_IN reference_NN sample_NN ,_, Cy_NNP 5_CD -_: dUTP_NN
          for_IN experimental_JJ sample_NN )_) ._. Pairs_NNP of_IN labeled_VBN cDNAs_NNS were_VBD
          hybridized_JJ to_TO microarray_NN slides_NNS for_IN 16_CD -_: 18_CD h_NN at_IN 65_CD °_NN C_NNP in_IN
          solution_NN with_IN blocking_VBG agents_NNS ._. After_IN several_JJ washes_NNS ,_,
          microarrays_NNS were_VBD scanned_JJ with_IN a_DT GenePix_NNP microarray_NN
          scanner_NN (_( Axon_NNP Instruments_NNP )_) and_CC were_VBD analyzed_VBN with_IN either_DT
          Scanalyze_NNP or_CC Genepix_NNP software_NN ._. After_IN visual_JJ inspection_NN ,_,
          spots_NNS of_IN insufficient_JJ quality_NN were_VBD flagged_JJ and_CC excluded_VBN
          from_IN further_JJ analysis_NN ._. Data_NNP files_NNS were_VBD entered_VBN into_IN the_DT
          Stanford_NNP Microarray_NNP Database_NNP [_NN 40_CD ]_NN ,_, and_CC compiled_VBN
          experimental_JJ data_NNS were_VBD further_RBR analyzed_VBD with_IN hierarchical_JJ
          clustering_VBG software_NN and_CC visualized_JJ with_IN Treeview_NNP software_NN
          [_NN 41_CD ,_, 42_CD ,_, 43_CD ]_NN ._. Identities_NNP of_IN genes_NNS or_CC hypothetical_JJ genes_NNS
          represented_VBN by_IN the_DT spotted_VBN cDNAs_NNS are_VBP based_VBN on_IN information_NN
          available_JJ in_IN UniGene_NNP cluster_NN Build_NNP 144_CD (_( November_NNP 2001_CD )_) [_NN
          44_CD ]_NN ._.
        
        
          Statistical_NNP analysis_NN of_IN microarray_NN data_NNS
          Genes_NNP with_IN potentially_RB significant_JJ changes_NNS in_IN
          expression_NN in_IN response_NN to_TO androgen_NN treatment_NN were_VBD
          identified_VBN using_VBG the_DT SAM_NNP procedure_NN [_NN 11_CD ,_, 45_CD ]_NN ._. Changes_NNS in_IN
          gene_NN expression_NN for_IN any_DT single_JJ gene_NN as_IN measured_VBN in_IN
          several_JJ array_NN experiments_NNS provide_VBP a_DT statistically_RB
          testable_JJ measure_NN of_IN robustness_NNS ,_, regardless_RB of_IN the_DT
          magnitude_NN of_IN change_NN in_IN expression_NN ._. The_DT SAM_NNP procedure_NN
          computes_VBZ a_DT two-sample_JJ T-_NNP statistic_NN (_( for_IN example_NN ,_, for_IN
          androgen-treated_JJ vs_NNS untreated_JJ cell_NN lines_NNS )_) for_IN the_DT
          normalized_JJ log_NN ratios_NNS of_IN gene-expression_JJ levels_NNS for_IN each_DT
          gene_NN ._. It_PRP thresholds_NNS the_DT T-_NNP statistics_NNS to_TO provide_VB a_DT
          '_POS significant_JJ '_POS gene_NN list_NN and_CC provides_VBZ an_DT estimate_NN of_IN the_DT
          false-discovery_JJ rate_NN (_( the_DT percentage_NN of_IN genes_NNS identified_VBN
          by_IN chance_NN alone_RB )_) from_IN randomly_RB permuted_JJ data_NNS ._.
          For_IN the_DT experiments_NNS described_VBD in_IN our_PRP$ study_NN ,_, the_DT raw_JJ
          expression_NN ratio_NN dataset_NN was_VBD filtered_VBN ,_, using_VBG the_DT program_NN
          Cluster_NNP [_NN 43_CD ]_NN ,_, for_IN genes_NNS whose_WP$ transcript_NN levels_NNS differ_VBP
          from_IN their_PRP$ median_JJ value_NN by_IN at_IN least_JJS 1_CD ._. 5_CD -_: fold_VB in_IN
          androgen-treated_JJ cells_NNS compared_VBN to_TO controls_NNS in_IN at_IN least_JJS
          two_CD experiments_NNS (_( with_IN not_RB more_JJR than_IN 30_CD %_NN of_IN measurements_NNS
          discarded_VBN because_IN of_IN poor_JJ data_NNS quality_NN for_IN each_DT entry_NN )_) ._.
          To_TO minimize_VB noise_NN ,_, only_RB genes_NNS with_IN fluorescent_NN intensity_NN
          in_IN each_DT channel_NN that_WDT was_VBD greater_JJR than_IN 1_CD ._. 4_CD times_NNS the_DT local_JJ
          background_NN were_VBD selected_VBN ._. Two_CD sets_NNS of_IN time-course_JJ
          experiments_NNS were_VBD included_VBN in_IN the_DT analysis_NN ._. The_DT filtered_VBN
          dataset_NN ,_, containing_VBG more_JJR than_IN 3_CD ,_, 900_CD genes_NNS ,_, was_VBD then_RB
          analyzed_VBN with_IN the_DT SAM_NNP procedure_NN ._. We_PRP used_VBD a_DT selection_NN
          threshold_NN giving_VBG a_DT median_JJ estimate_NN of_IN 0_CD ._. 5_CD false-positive_JJ
          genes_NNS (_( false_JJ detection_NN rate_NN of_IN 0_CD ._. 088_CD %_NN )_) for_IN further_JJ
          analysis_NN ._. This_DT list_NN consists_VBZ of_IN 517_CD unique_JJ genes_NNS (_( of_IN 568_CD
          total_JJ cDNAs_NNS )_) of_IN which_WDT 421_CD are_VBP induced_VBN and_CC 96_CD are_VBP
          repressed_VBN by_IN exposure_NN to_TO R_NN 1881_CD ._.
        
      
      
        Additional_JJ data_NNS files_NNS
        Supplemental_NN figures_NNS showing_VBG full_JJ gene_NN names_NNS and_CC GenBank_NNP
        accession_NN numbers_NNS for_IN Figures_NNS 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD and_CC 5_CD are_VBP available_JJ
        and_CC at_IN [_NN 12_CD ]_NN ._.
        Additional_JJ data_NNS file_VBP 1_CD
        Full_NNP gene_NN names_NNS and_CC GenBank_NNP accession_NN numbers_NNS for_IN Figure_NN
        1_CD
        Full_NNP gene_NN names_NNS and_CC GenBank_NNP accession_NN numbers_NNS for_IN Figure_NN
        1_CD
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 2_CD
        Full_NNP gene_NN names_NNS and_CC GenBank_NNP accession_NN numbers_NNS for_IN Figure_NN
        2_CD
        Full_NNP gene_NN names_NNS and_CC GenBank_NNP accession_NN numbers_NNS for_IN Figure_NN
        2_CD
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 3_CD
        Full_NNP gene_NN names_NNS and_CC GenBank_NNP accession_NN numbers_NNS for_IN Figure_NN
        3_CD
        Full_NNP gene_NN names_NNS and_CC GenBank_NNP accession_NN numbers_NNS for_IN Figure_NN
        3_CD
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 4_CD
        Full_NNP gene_NN names_NNS and_CC GenBank_NNP accession_NN numbers_NNS for_IN Figure_NN
        4_CD
        Full_NNP gene_NN names_NNS and_CC GenBank_NNP accession_NN numbers_NNS for_IN Figure_NN
        4_CD
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
        Additional_JJ data_NNS file_VBP 5_CD
        Full_NNP gene_NN names_NNS and_CC GenBank_NNP accession_NN numbers_NNS for_IN Figure_NN
        5_CD
        Full_NNP gene_NN names_NNS and_CC GenBank_NNP accession_NN numbers_NNS for_IN Figure_NN
        5_CD
        Click_NNP here_RB for_IN additional_JJ data_NNS file_VBP
      
    
  
